Testosterone replacement therapy is associated with an increased risk of urolithiasis
Testosterone replacement therapy is associated with an increased risk of urolithiasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Testosterone replacement therapy is associated with an increased risk of urolithiasis have?
Testosterone replacement therapy is associated with an increased risk of urolithiasis has 15 citations in the OpenAlex counts ScholarIQ stores.
When was Testosterone replacement therapy is associated with an increased risk of urolithiasis published?
Testosterone replacement therapy is associated with an increased risk of urolithiasis has 2019 year in the ScholarIQ index.
What is the open-access status of Testosterone replacement therapy is associated with an increased risk of urolithiasis?
Testosterone replacement therapy is associated with an increased risk of urolithiasis has closed oa status in the ScholarIQ index.
What is the DOI of Testosterone replacement therapy is associated with an increased risk of urolithiasis?
The DOI for Testosterone replacement therapy is associated with an increased risk of urolithiasis is on the source record.
What is the PMID of Testosterone replacement therapy is associated with an increased risk of urolithiasis?
The PMID for Testosterone replacement therapy is associated with an increased risk of urolithiasis is on the source record.
What is the OpenAlex record for Testosterone replacement therapy is associated with an increased risk of urolithiasis?
The OpenAlex for Testosterone replacement therapy is associated with an increased risk of urolithiasis is on the source record.